Health Special: Lupus and Plasminogen Deficiency
November 6, 2017
Treatment and Trials for Lupus and Plasminogen Deficiency.
This episode of The Balancing Act focuses on two very different diseases: Lupus and Plasminogen Deficiency (PLGD). Fortunately, research is yielding encouraging treatment options for both diseases.
The Lupus Foundation of America estimates that 1.5 million Americans — and at least five million people worldwide — have a form of lupus. Join us for a discussion of lupus and lupus nephritis, meet two courageous women who are battling the disease, plus we examine the latest clinical trials giving hope to medical professionals and sufferers.
Then, in our recurring Behind the Mystery segment, we examine Plasminogen Deficiency (PLGD) or Hypoplasminogenemia, an ultra-rare disease often misdiagnosed. A systemic and potentially life-threatening disease, PLGD frequently presents with ligneous conjunctivitis, an eye condition where the lids develop membranous growths. We meet a young lady who has been dealing with PLGD almost since birth, along with her mother, who has become a vocal advocate.
The Rockefeller Foundation is working to give communities the food, income, and benefits they need to survive by providing access to various helpful resources.
Homesquare offers an extensive and curated range of functional, stylish, and modern furniture that allows customers to create their dream home office.
The Balancing Act is back, exploring ways to survive and thrive during the coronavirus pandemic – from mental health to creating your dream workspace.